Purpose
The isolation rate of extended spectrum β-lactamase (ESBL)-producing
Escherichia coli
is increasing, posing a challenge to clinical anti-infective therapy. This study aims to provide new insight into the genomic characteristics and antimicrobial resistance mechanisms of extended spectrum β-lactamase producing
E. coli
isolates recovered from a district hospital in China.
Methods
A total of 36 ESBL-producing
E. coli
isolates were collected from body fluid samples from a Chinese district hospital. All isolates were subjected to whole genome sequencing to identify their antimicrobial resistance genes, virulence genes, serotypes, sequence types, and phylogenetic relationships by BacWGSTdb 2.0 webserver.
Results
Among these isolates, all were resistant to cefazolin, cefotaxime, ceftriaxone, ampicillin, 24 (66.7%) were resistant to aztreonam, 16 (44.4%) were resistant to cefepime, and 15 were resistant (41.7%) to ceftazidime. The
bla
CTX-M
gene was detected in all ESBL-producing
E. coli
isolates. Two isolates carrying two different types of
bla
CTX-M
genes simultaneously. The carbapenem resistance gene
bla
KPC-2
was detected in one (2.8%) isolate. A total of 17 sequence types (STs) were found, with ST131 accounting for the majority (n =13; 36.1%). The most common serotype was O16:H5 associated with seven ST131 strains, followed by O25:H4/ST131 (n = 5) and O75:H5/ST1193 (n = 5). Evaluation of clonal relatedness revealed that all
bla
CTX-M
gene-carrying
E. coli
had a difference of SNPs range from 7 to 79,198, which could be divided into four clusters. Only 7 SNPs could be found between EC266 and EC622, indicating that they are variants of the same clonal lineage.
Conclusion
This study investigated the genomic characteristics of ESBL-producing
E. coli
isolates recovered from a district hospital in China. Continuous surveillance of ESBL-producing
E. coli
infections is imperative to create efficient strategies for controlling the transmission of these multi-drug resistant bacteria in clinical and community settings.